SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nashel DJ, Ulmer CC. Systemic lupus erythematosus: important considerations in the adolescent. J Adolesc Health Care 1982; 2: 2738.
  • 2
    Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005; 80: 2633.
  • 3
    Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101: 51825.
  • 4
    Dietz WH, Robinson TN. Clinical practice: overweight children and adolescents. N Engl J Med 2005; 352: 21009.
  • 5
    Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 236274.
  • 6
    Sakuragi S, Abhayaratna K, O'Reilly C, Srikusalanukul W, Gravenmaker K, Budge M, et al. Influence of adiposity on arterial stiffness in healthy children[abstract]. Circulation 2008; 118: S1115.
  • 7
    Le J, Spencer M, McCrary D, Zhang D, Jie C, Raghuveer G. Advanced “vascular age” in children with dyslipidemia [abstract]. Circulation 2008; 118: S1056.
  • 8
    Ayer JG, Sholler G, Celermajer DS. Left atrial size is independently associated with body mass index in children [abstract]. Circulation 2008; 118: S1154.
  • 9
    Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 232937.
  • 10
    Ludwig DS, Ebbeling CB. Overweight children and adolescents [letter]. N Engl J Med 2005; 353: 10701.
  • 11
    Daniels S, Jacobson M, McCrindle B, Eckel R, McHugh SB. American Heart Association childhood obesity research summit report. Circulation 2009; 119: e489517.
  • 12
    Guo SS, Chumlea WC. Tracking of body mass index in children in relation to overweight in adulthood. Am J Clin Nutr 1999; 70: 145S8S.
  • 13
    Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337: 86973.
  • 14
    Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 18793.
  • 15
    Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 76378.
  • 16
    Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004; 351: 2694703.
  • 17
    Ford AL, Hunt LP, Cooper A, Shield JP. What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health? Arch Dis Child 2010; 95: 25661.
  • 18
    Tekano JL, Tucker L, Khattra P. Limiting obesity in children with rheumatic diseases requiring corticosteroid therapy [abstract]. Arthritis Rheum 2006; 54 Suppl: S529.
  • 19
    Takken T, van der Net J, Helders PJ. Relationship between functional ability and physical fitness in juvenile idiopathic arthritis patients. Scand J Rheumatol 2003; 32: 1748.
  • 20
    Van Brussel M, Lelieveld OT, van der Net J, Engelbert RH, Helders PJ, Takken T. Aerobic and anaerobic exercise capacity in children with juvenile idiopathic arthritis. Arthritis Rheum 2007; 57: 8917.
  • 21
    Klepper S. Making the case for exercise in children with juvenile idiopathic arthritis: what we know and where we go from here. Arthritis Rheum 2007; 57: 88790.
  • 22
    Lelieveld OT, van Brussel M, Takken T, van Weert E, van Leeuwen MA, Armbrust W. Aerobic and anaerobic exercise capacity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum 2007; 57: 898904.
  • 23
    Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure D, et al, and the Canadian Steroid -Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 2010; 62: 51626.
  • 24
    Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, et al, and the Canadian Steroid -Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 2012; 64: 12231.
  • 25
    Halton J, Gaboury I, Grant R, Alos N, Cummings EA, Matzinger M, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 2009; 24: 132634.
  • 26
    Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 4560.
  • 27
    Hay J. Development and testing of the Habitual Activity Estimation Scale. In: Armstrong N. Children and exercise XIX. 2nd ed. Exeter: Singer Press; 2006.
  • 28
    Hay JA, Cairney J. Development of the Habitual Activity Estimation Scale for clinical research: a systematic approach. Pediatr Exerc Sci 2006; 18: 193.
  • 29
    Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Arthritis Rheum 1997; 40: 197683.
  • 30
    Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291303.
  • 31
    Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 1323.
  • 32
    Morris NM, Udry JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980; 9: 27180.
  • 33
    Cassidy J, Petty R, Laxer R, Lindsley C, editors. The textbook of pediatric rheumatology. 6th ed. Philadelphia: Elsevier Saunders; 2011.
  • 34
    DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012; 64: 100110.
  • 35
    Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 2002; 61: 71822.
  • 36
    Wells GD, Wilkes DL, Schneiderman-Walker J, Elmi M, Tullis E, Lands LC, et al. Reliability and validity of the Habitual Activity Estimation Scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol 2008; 43: 34553.
  • 37
    Schneiderman-Walker J, Wilkes DL, Strug L, Lands LC, Pollock SL, Selvadurai HC, et al. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr 2005; 147: 3216.
  • 38
    Van Gent R, van der Ent CK, van Essen-Zandvliet LE, Rovers MM, Kimpen JL, de Meer G, et al. No differences in physical activity in (un)diagnosed asthma and healthy controls. Pediatr Pulmonol 2007; 42: 101823.
  • 39
    Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 2006; 35: 3847.
  • 40
    Thayu M, Denson LA, Shults J, Zemel BS, Burnham JM, Baldassano RN, et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology 2010; 139: 4308.
  • 41
    R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2011. URL: http://www.R-project.org/.
  • 42
    Foster BJ, Shults J, Zemel BS, Leonard MB. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2006; 21: 97380.
  • 43
    Elzouki AY, Jaiswal OP. Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood: effect on remission, statural growth, obesity, and infection rate. Clin Pediatr (Phila) 1988; 27: 38792.
  • 44
    Merritt RJ, Hack SL, Kalsch M, Olson D. Corticosteroid therapy-induced obesity in children. Clin Pediatr (Phila) 1986; 25: 14952.
  • 45
    Neovius M, Linne Y, Barkeling B, Rossner S. Discrepancies between classification systems of childhood obesity. Obes Rev 2004; 5: 10514.
  • 46
    Lilleby V, Haugen M, Morkrid L, Frey Froslie K, Holven KB, Forre O. Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus. Scand J Rheumatol 2007; 36: 407.
  • 47
    Mul D, van Suijlekom-Smit LW, ten Cate R, Bekkering WP, de Muinck Keizer-Schrama SM. Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol 2002; 15: 18792.
  • 48
    Adamo K, Prince S, Tricco A, Connor-Gorber S, Tremblay M. A comparison of indirect versus direct measures for assessing physical activity in the pediatric population: a systematic review. Int J Pediatr Obes 2009; 4: 227.